A citation-based method for searching scientific literature

Úna M McVeigh, Terri P McVeigh, Catherine Curran, Nicola Miller, Derek W Morris, Micheal J Kerin. Ir J Med Sci 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.
Tamar Yablonski-Peretz, Shani Paluch-Shimon, Lior Soussan Gutman, Yulia Kaplan, Addie Dvir, Inbal Barnes-Kedar, Luna Kadouri, Valeriya Semenisty, Noa Efrat, Victoria Neiman,[...]. Breast Cancer Res Treat 2016
14
100

The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
Pi-Lin Sung, Kuo-Chang Wen, Yi-Jen Chen, Ta-Chung Chao, Yi-Fang Tsai, Ling-Ming Tseng, Jian-Tai Timothy Qiu, Kuan-Chong Chao, Hua-Hsi Wu, Chi-Mu Chuang,[...]. PLoS One 2017
18
100

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
418
100

Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.
Ava Kwong, Vivian Y Shin, Jiawei Chen, Isabella W Y Cheuk, Cecilia Y S Ho, Chun H Au, Karen K L Chan, Hextan Y S Ngan, Tsun L Chan, James M Ford,[...]. J Mol Diagn 2020
9
100

Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
Olivia Moran, Dina Nikitina, Robert Royer, Aletta Poll, Kelly Metcalfe, Steven A Narod, Mohammad R Akbari, Joanne Kotsopoulos. Breast Cancer Res Treat 2017
25
100

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Laurent Castéra, Sophie Krieger, Antoine Rousselin, Angélina Legros, Jean-Jacques Baumann, Olivia Bruet, Baptiste Brault, Robin Fouillet, Nicolas Goardon, Olivier Letac,[...]. Eur J Hum Genet 2014
174
100

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
100

Hereditary truncating mutations of DNA repair and other genes in BRCA1/BRCA2/PALB2-negatively tested breast cancer patients.
F Lhota, P Zemankova, P Kleiblova, J Soukupova, M Vocka, V Stranecky, M Janatova, H Hartmannova, K Hodanova, S Kmoch,[...]. Clin Genet 2016
31
100

Multigene panels in Ashkenazi Jewish patients yield high rates of actionable mutations in multiple non-BRCA cancer-associated genes.
Melissa K Frey, Gabriella Sandler, Rachel Sobolev, Sarah H Kim, Rachelle Chambers, Rebecca Y Bassett, Jessica Martineau, Katherine J Sapra, Leslie Boyd, John P Curtin,[...]. Gynecol Oncol 2017
14
100

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.
J Maksimenko, A Irmejs, G Trofimovičs, D Bērziņa, E Skuja, G Purkalne, E Miklaševičs, J Gardovskis. Hered Cancer Clin Pract 2018
7
100

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
245
100

Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes.
Jiayu Wang, Weiwei Li, Yujian Shi, Yan Huang, Tao Sun, Lili Tang, Qing Lu, Qiumo Lei, Ning Liao, Feng Jin,[...]. Cancer Med 2019
16
100

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.
Elodie Girard, Séverine Eon-Marchais, Robert Olaso, Anne-Laure Renault, Francesca Damiola, Marie-Gabrielle Dondon, Laure Barjhoux, Didier Goidin, Vincent Meyer, Dorothée Le Gal,[...]. Int J Cancer 2019
33
100

Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
Mario Capasso, Marcella Devoto, Cuiping Hou, Shahab Asgharzadeh, Joseph T Glessner, Edward F Attiyeh, Yael P Mosse, Cecilia Kim, Sharon J Diskin, Kristina A Cole,[...]. Nat Genet 2009
222
100

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
Milagros González-Rivera, Miriam Lobo, Sara López-Tarruella, Yolanda Jerez, María Del Monte-Millán, Tatiana Massarrah, Rocío Ramos-Medina, Inmaculada Ocaña, Antoni Picornell, Sonia Santillán Garzón,[...]. Breast Cancer Res Treat 2016
24
100

Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an example.
Katarzyna Klonowska, Magdalena Ratajska, Karol Czubak, Alina Kuzniacka, Izabela Brozek, Magdalena Koczkowska, Marcin Sniadecki, Jaroslaw Debniak, Dariusz Wydra, Magdalena Balut,[...]. Sci Rep 2015
25
100

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
294
100

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
Piera Rizzolo, Veronica Zelli, Valentina Silvestri, Virginia Valentini, Ines Zanna, Simonetta Bianchi, Giovanna Masala, Alessandro Mauro Spinelli, Maria Grazia Tibiletti, Antonio Russo,[...]. Int J Cancer 2019
24
100

Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes.
Anna Guacci, Angela Cordella, Teresa Rocco, Giorgio Giurato, Giovanni Nassa, Francesca Rizzo, Chiara Carlomagno, Stefano Pepe, Roberta Tarallo, Alessandro Weisz. J Clin Lab Anal 2018
5
100

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
347
100

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
Jenna Lilyquist, Holly LaDuca, Eric Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N Hart, Jill S Dolinsky, Fergus J Couch, David E Goldgar. Gynecol Oncol 2017
66
100

New germline BRCA2 gene variant in the Tuvinian Mongol breast cancer patients.
Polina Gervas, Boris Klyuch, Evgeny Denisov, Artem Kiselev, Alexey Molokov, Lubov Pisareva, Elena Malinovskaya, Evgeny Choynzonov, Nadezda Cherdyntseva. Mol Biol Rep 2019
5
100

Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families.
Sylvia De Brakeleer, Jacques De Grève, Remy Loris, Nicolas Janin, Willy Lissens, Erica Sermijn, Erik Teugels. Hum Mutat 2010
62
100

Germline variants in cancer genes in high-risk non-BRCA patients from Puerto Rico.
Julie Dutil, Jamie K Teer, Volha Golubeva, Sean Yoder, Wei Lue Tong, Nelly Arroyo, Rachid Karam, Miguel Echenique, Jaime L Matta, Alvaro N Monteiro. Sci Rep 2019
10
100

Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer.
Yosuke Hirotsu, Hiroshi Nakagomi, Ikuko Sakamoto, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki, Masao Omata. Mol Genet Genomic Med 2015
60
100

Next-generation sequencing in familial breast cancer patients from Lebanon.
Nadine Jalkh, Eliane Chouery, Zahraa Haidar, Christina Khater, David Atallah, Hamad Ali, Makia J Marafie, Mohamed R Al-Mulla, Fahd Al-Mulla, Andre Megarbane. BMC Med Genomics 2017
28
100

Synchronous endometrioid endometrial and ovarian carcinomas are biologically related: A clinico-pathological and molecular (next generation sequencing) study of 22 cases.
Nikola Hájková, Ivana Tichá, Jan Hojný, Kristýna Němejcová, Michaela Bártů, Romana Michálková, Michal Zikán, David Cibula, Jan Laco, Tomáš Geryk,[...]. Oncol Lett 2019
8
100

Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.
Iulian Gabriel Goidescu, Gabriela Caracostea, Dan Tudor Eniu, Florin Vasile Stamatian. Clujul Med 2018
8
100

Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.
Suhair Lolas Hamameh, Paul Renbaum, Lara Kamal, Dima Dweik, Mohammad Salahat, Tamara Jaraysa, Amal Abu Rayyan, Silvia Casadei, Jessica B Mandell, Suleyman Gulsuner,[...]. Int J Cancer 2017
26
100

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
201
100

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
Simone da Costa E Silva Carvalho, Nathalia Moreno Cury, Danielle Barbosa Brotto, Luiza Ferreira de Araujo, Reginaldo Cruz Alves Rosa, Lorena Alves Texeira, Jessica Rodrigues Plaça, Adriana Aparecida Marques, Kamila Chagas Peronni, Patricia de Cássia Ruy,[...]. BMC Med Genomics 2020
21
100

Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing.
P S Ng, W X Wen, M Z H Fadlullah, S Y Yoon, S Y Lee, M K Thong, C H Yip, N A Mohd Taib, S H Teo. Clin Genet 2016
9
100

Mutational analysis of BARD1 in familial breast cancer patients in Japan.
Makoto Ishitobi, Yasuo Miyoshi, Seiichi Hasegawa, Chiyomi Egawa, Yasuhiro Tamaki, Morito Monden, Shinzaburo Noguchi. Cancer Lett 2003
56
100

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Georgios N Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi,[...]. BMC Cancer 2019
48
100


Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.
Aleksandra I Adamovich, Tapahsama Banerjee, Margaret Wingo, Kathryn Duncan, Jie Ning, Fernanda Martins Rodrigues, Kuan-Lin Huang, Cindy Lee, Feng Chen, Li Ding,[...]. PLoS Genet 2019
17
100

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.
Kyosuke Nakamura, Giulia Saredi, Jordan R Becker, Benjamin M Foster, Nhuong V Nguyen, Tracey E Beyer, Laura C Cesa, Peter A Faull, Saulius Lukauskas, Thomas Frimurer,[...]. Nat Cell Biol 2019
88
100

The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
R Hashizume, M Fukuda, I Maeda, H Nishikawa, D Oyake, Y Yabuki, H Ogata, T Ohta. J Biol Chem 2001
524
100

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
219
100

Complex Landscape of Germline Variants in Brazilian Patients With Hereditary and Early Onset Breast Cancer.
Giovana T Torrezan, Fernanda G Dos Santos R de Almeida, Márcia C P Figueiredo, Bruna D de Figueiredo Barros, Cláudia A A de Paula, Renan Valieris, Jorge E S de Souza, Rodrigo F Ramalho, Felipe C C da Silva, Elisa N Ferreira,[...]. Front Genet 2018
16
100

Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families.
Laurent Castéra, Valentin Harter, Etienne Muller, Sophie Krieger, Nicolas Goardon, Agathe Ricou, Antoine Rousselin, Germain Paimparay, Angelina Legros, Olivia Bruet,[...]. Genet Med 2018
45
100

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Di Shao, Shaomin Cheng, Fengming Guo, Changbin Zhu, Yuying Yuan, Kunling Hu, Zhe Wang, Xuan Meng, Xin Jin, Yun Xiong,[...]. Cancer Sci 2020
10
100

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
640
100

Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Magdalena Ratajska, Ewelina Antoszewska, Anna Piskorz, Izabela Brozek, Åke Borg, Hanna Kusmierek, Wojciech Biernat, Janusz Limon. Breast Cancer Res Treat 2012
68
100

ClinVar: improving access to variant interpretations and supporting evidence.
Melissa J Landrum, Jennifer M Lee, Mark Benson, Garth R Brown, Chen Chao, Shanmuga Chitipiralla, Baoshan Gu, Jennifer Hart, Douglas Hoffman, Wonhee Jang,[...]. Nucleic Acids Res 2018
100

Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Yong Alison Wang, Jhih-Wei Jian, Chen-Fang Hung, Hung-Pin Peng, Chi-Fan Yang, Hung-Chun Skye Cheng, An-Suei Yang. BMC Cancer 2018
41
100

Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.
Anna P Sokolenko, Elena V Preobrazhenskaya, Svetlana N Aleksakhina, Aglaya G Iyevleva, Natalia V Mitiushkina, Olga A Zaitseva, Olga S Yatsuk, Vladislav I Tiurin, Tatiana N Strelkova, Alexandr V Togo,[...]. Cancer Lett 2015
23
100

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
Philipp Harter, Jan Hauke, Florian Heitz, Alexander Reuss, Stefan Kommoss, Frederik Marmé, André Heimbach, Katharina Prieske, Lisa Richters, Alexander Burges,[...]. PLoS One 2017
65
100

Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.
Eric Hahnen, Bianca Lederer, Jan Hauke, Sibylle Loibl, Sandra Kröber, Andreas Schneeweiss, Carsten Denkert, Peter A Fasching, Jens U Blohmer, Christian Jackisch,[...]. JAMA Oncol 2017
210
100

Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
Magdalena Ratajska, Magdalena Matusiak, Alina Kuzniacka, Bartosz Wasag, Izabela Brozek, Wojciech Biernat, Magdalena Koczkowska, Jaroslaw Debniak, Marcin Sniadecki, Piotr Kozlowski,[...]. Oncol Rep 2015
18
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.